The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,244.00
Bid: 1,234.00
Ask: 1,239.00
Change: 18.00 (1.47%)
Spread: 5.00 (0.405%)
Open: 1,226.00
High: 1,245.00
Low: 1,226.00
Prev. Close: 1,226.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completed Share Purchase by Employee Benefit Trust

7 Apr 2021 17:16

RNS Number : 7387U
Burford Capital Limited
07 April 2021
 

 

 

7 April 2021

 

 

COMPLETED PURCHASE OF SHARES BY EMPLOYEE BENEFIT TRUST

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces that it was notified by the Trustee of the Burford Capital Employee Benefit Trust ("EBT") that it has completed the purchase in the market of 116,729 of Burford's Ordinary Shares in accordance with the Company's irrevocable instruction. Details of the completed purchases are as follows:

 

Date

Stock Exchange

Number of Ordinary Shares Acquired

Average Net Price Paid per Share

March 30

LSE

11,098

615.447p

March 30

NYSE

600

$8.43000

March 31

LSE

4,902

621.366p

March 31

NYSE

2,000

$8.82571

April 1

NYSE

40,733

$9.79294

April 5

NYSE

32,500

$10.1186

April 6

NYSE

24,896

$10.1971

 

The weighted average price of the purchases at the London Stock Exchange was 617.260p per share, while the weighted average price of the purchases at the New York Stock Exchange was $9.97058 per share.

 

As previously announced, the purchased shares will be held by the Trustee in the Company's EBT and used to satisfy vested awards made under Burford's Long Term Incentive Plan. The EBT is a discretionary trust for the benefit of the employees of the Company and its subsidiaries.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Kevin Cruickshank (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this report. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this report, whether as a result of new information, future events, a change in our views or expectations or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREAKLXEFSFEFA
Date   Source Headline
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust
20th Sep 20218:30 amRNSDirector/PDMR Shareholding
17th Sep 20218:30 amRNSDirector/PDMR Shareholding
16th Sep 20218:30 amRNSIntended Share Purchase by Employee Benefit Trust
16th Sep 20217:00 amRNSCompleted Share Purchase for NED Share Plan
15th Sep 202111:00 amRNSDirector/PDMR Shareholding
15th Sep 20218:30 amRNSIntended Share Purchase for NED Share Plan
9th Sep 202112:12 pmRNSNotice of Investor Event Date
9th Sep 202112:12 pmRNSInterim Results for six months ended 30 June 2021
26th Aug 20213:00 pmRNSNotice of 1H21 Results Call Registration Details
23rd Aug 20217:00 amRNSBusiness Performance Update and US GAAP Conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.